ABOUT THIS BOOK
PUBLISHER: John Wiley and Sons Ltd
FORMAT: Electronic book text
ISBN: 9783527807246
RRP: £126.00
PAGES: 382
PUBLICATION DATE:
August 17, 2018
BUY THIS BOOK
As an Amazon Associate and Bookshop.org affiliate we earn from qualifying purchases.
Catalytic Processes for API Synthesis: From Laboratory to Industry
Anthony J. Burke
Carolina Silva Marques
Nicholas Turner
Gesine Hermann
This timely reference presents the most effective catalytic reactions in use today, with a special focus on process intensification, sustainability, waste reduction and innovative methods.The book demonstrates the importance of efficient catalytic transformations for producing pharmaceutically active molecules, discussing every key reaction and the most efficient catalytic processes, including their major advantages compared to previous methods, with a strong emphasis throughout on asymmetric catalytic reactions.Of great interest to synthetic chemists working in the pharmaceutical industry, and for fine-chemical companies and other R&D researchers, as well as for chemists in academia.
Anthony J. Burke
Anthony J. Burke is Professor at the University of Evora. His interests lie mostly in the areas of asymmetric synthesis and catalysis, reaction mechanisms and medicinal chemistry. He is currently the coordinator of the organic and organometallic research line at the Centro de Qu�mica de Evora. He is the co-author of one book, one book chapter with about 80 international articles and patents to date.Carolina S. Marques is working as a PostDoc in the Burke group. Her current interests are the development of new catalytic systems and methodologies for the synthesis of chiral amines and other important targets. She is the co-author of one book, and has about 30 international publications, which includes two important review articles, patents and has communicated her work both nationally and internationally on a frequent basis.Nicholas Turner is Professor of Chemical Biology, Director of the Centre of Excellence in Biocatalysis (CoEBio3) and co-Director of SYNBIOCHEM. His research interests are in biocatalysis, directed evolution of enzymes and synthetic biology. He has published 250 papers/patents with an H-index of 46 and over 9,000 citations. He is a member of several Scientific Advisory Boards and consults widely. He has received many awards for his research achievements.Gesine J. Hermann is a research and business consultant for ChiraTecnics, Portugal. In her career she has co-authored a number of publications and patents. She studied chemistry in Germany at the University of Frankfurt from where she graduated in 1991. In 1995 she completed her PhD at the University of Heidelberg under the supervision of Professor Albrecht Berkessel. After postdoctoral studies at the University of Oxford with Professor Steve Davies she then began her professional career as a process development scientist and held different positions in international pharma companies.